PPARα targets Non-alcoholic fatty liver disease
Evidence from:
primary |
all sources
Evidence (1 sources)
Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
(2016)
PMID:26838599
cited
PPARα as a drug target for NAFLD treatment
confidence: 0.93